MRGOO3
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MRGOO3, covering 2025-12-05 to 2025-12-05. Get the full timeline:
Most recent: Clinical Trial Update: Pembrolizumab + MRGOO3 as Neoadjuvant in NPC [Phase 2]